Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Breast Neoplasms 109Carcinoma, Non-Small-Cell Lung 104Prostatic Neoplasms 87Multiple Myeloma 73Neoplasms 70Lung Neoplasms 61Colorectal Neoplasms 49Neoplasm Metastasis 43Leukemia, Myeloid, Acute 42Melanoma 38Lymphoma, Non-Hodgkin 37Lymphoma 37Pancreatic Neoplasms 36Carcinoma, Renal Cell 35Ovarian Neoplasms 34Leukemia, Lymphocytic, Chronic, B-Cell 32Urinary Bladder Neoplasms 31Squamous Cell Carcinoma of Head and Neck 31Endometrial Neoplasms 28Precursor Cell Lymphoblastic Leukemia-Lymphoma 27Uterine Cervical Neoplasms 26Hematologic Neoplasms 26Sarcoma 24Glioma 24Carcinoma, Hepatocellular 24Triple Negative Breast Neoplasms 23Stomach Neoplasms 23Recurrence 21Head and Neck Neoplasms 21Brain Neoplasms 21

Interventions

pembrolizumab 1Fluorouracil 1Cisplatin 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Malignant Solid Tumor × 30 days × Clear all
NCT06057038 2026-06-02

A Safety Trial of GEN1042 in Japanese Subjects With Malignant Solid Tumors

Genmab

Phase 1 Active not recruiting
42 enrolled
Other solid neoplasm

Malignant Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡